Dead languages aren't as unimportant as they seem, because learning Latin, Sanskrit and Ancient Greek will make coding easier ...

Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

‘Tis the season for reflecting on a well-read year. So, after all that reading, which books are we still thinking about now? The truth is, the best book of the year is deeply personal to every reader.

Another year, another stack of great books to read. Jeffrey Brown talked with Maureen Corrigan, book critic for NPR’s Fresh Air, and author Ann Patchett about their top picks this year. The Loneliness ...

Monday - Friday, 6:00 - 7:00 PM ET It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

The Frankfurt Book Fair opens its 77th edition with a robust lineup of professional programming for today—Wednesday, October 15. From CEO conversations to diversity panels, children’s publishing ...

This year’s longlist includes five books by writers who have published short fiction in The New Yorker: Susan Choi, Jonas Hassen Khemiri, Karen Russell, Bryan Washington, and Joy Williams. Two ...

This AI company isn't yet living up to the hype. Let's discuss Recursion Pharmaceuticals' performance over the past four years and whether the company can deliver solid returns in the future. It can ...

Recent discussions on X about Recursion Pharmaceuticals (RXRX) have centered around the company's notable stock price surge of 14% over the past month, a performance that stands out against a ...